en: They found that 6.4 percent of men on finasteride had high-grade tumors , compared with 5.1 percent taking a placebo . About 18 percent of men taking finasteride developed prostate cancer , compared with 24 percent on placebo .
ms: Mereka mendapati bahawa 6.4 peratus lelaki pada finasteride mempunyai tumor gred tinggi, berbanding dengan 5.1 peratus mengambil plasebo. Kira-kira 18 peratus lelaki yang mengambil finasteride mengembangkan kanser prostat, berbanding dengan 24 peratus pada plasebo.